Market capitalization | €2.93b |
Enterprise Value | €2.99b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 145.96 |
EV/Sales (TTM) EV/Sales | 1.34 |
P/S ratio (TTM) P/S ratio | 1.31 |
P/B ratio (TTM) P/B ratio | 5.79 |
Revenue growth (TTM) Revenue growth | 39.58% |
Revenue (TTM) Revenue | €2.23b |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
13 Analysts have issued a Redcare Pharmacy forecast:
13 Analysts have issued a Redcare Pharmacy forecast:
Sep '24 |
+/-
%
|
||
Revenue | 2,227 2,227 |
40%
40%
|
|
Gross Profit | 448 448 |
24%
24%
|
|
EBITDA | 30 30 |
69%
69%
|
EBIT (Operating Income) EBIT | -39 -39 |
189%
189%
|
Net Profit | -25 -25 |
51%
51%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Shop Apotheke Europe NV engages in the provision of medication and pharmacy-related beauty and care products. It operates through the DACH and International geographical segments. The DACH segment sells prescription medicine, prescription-free pharmaceuticals, and beauty and personal care products, and functional food products to individual customers located in the German, the Austrian, and the Swiss market. The International segment trades pharmaceutical products outside European market. The company was founded by Stephan Weber and Marc Fischer in 2001 and is headquartered in Venlo, the Netherlands.
Head office | Netherlands |
CEO | Olaf Heinrich |
Employees | 2,075 |
Founded | 2001 |
Website | www.redcare-pharmacy.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.